192
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Incidence of and Mortality Due to Human Prion Diseases in Taiwan: A Prospective 20-Year Nationwide Surveillance Study from 1998 to 2017

ORCID Icon, , , , , , ORCID Icon, & ORCID Icon show all
Pages 1073-1081 | Published online: 14 Oct 2020

References

  • Caramelli M, Ru G, Acutis P, Forloni G. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances. CNS Drugs. 2006;20(1):15–28. doi:10.2165/00023210-200620010-0000216396521
  • Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10. doi:10.1016/S1473-3099(19)30615-231876504
  • Lu CJ, Sun Y, Chen SS. Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance. Eur J Epidemiol. 2010;25(5):341–347. doi:10.1007/s10654-010-9446-420333444
  • Doi Y, Yokoyama T, Sakai M, Nakamura Y. Creutzfeldt-Jakob disease mortality in Japan, 1979–2004: analysis of national death certificate data. J Epidemiol. 2007;17(4):133–139. doi:10.2188/jea.17.13317641449
  • Ruegger J, Stoeck K, Amsler L, et al. A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001–2004. BMC Public Health. 2009;9:18. doi:10.1186/1471-2458-9-1819144172
  • Cousens SN, Zeidler M, Esmonde TF, et al. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970–96. BMJ. 1997;315(7105):389–395. doi:10.1136/bmj.315.7105.3899277601
  • Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987;37(6):895–904. doi:10.1212/WNL.37.6.8953295589
  • Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH. Frontal variant of Alzheimer’s disease with asymmetric presentation mimicking frontotemporal dementia: case report and literature review. Brain Behav. 2020;10(3). doi:10.1002/brb3.1548
  • Nagoshi K, Sadakane A, Nakamura Y, Yamada M, Mizusawa H. Duration of prion disease is longer in Japan than in other countries. J Epidemiol. 2011;21(4):255–262. doi:10.2188/jea.JE2010008521628843
  • Chen TF, Tang MC, Chou CH, Chiu MJ, Huang RFS. Dose-dependent folic acid and memantine treatments promote synergistic or additive protection against A beta((25–35)) peptide-induced apoptosis in SH-SY5Y cells mediated by mitochondria stress-associated death signals. Food Chem Toxicol. 2013;62::538–547. doi:10.1016/j.fct.2013.09.015
  • Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain: J Neurol. 2006;129(Pt 9):2278–2287. doi:10.1093/brain/awl159
  • D’Arcy CE, Bitnun A, Coulthart MB, et al. Sporadic Creutzfeldt-Jakob disease in a young girl with unusually long survival. J Neuropathol Exp Neurol. 2019;78(4):373–378. doi:10.1093/jnen/nlz01330856268
  • Hayashi Y, Iwasaki Y, Waza M, et al. Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease. Prion. 2020;14(1):109–117. doi:10.1080/19336896.2020.173960332178563
  • Wang J, Xiao K, Zhou W, Shi Q, Dong XP. Analysis of 12 Chinese patients with proline-to-leucine mutation at codon 102-associated Gerstmann-Straussler-Scheinker disease. J Clin Neurol. 2019;15(2):184–190. doi:10.3988/jcn.2019.15.2.18430877692
  • WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation, Geneva, Switzerland, 9–11 February 1998. 1998 Available from: https://appswhoint/iris/handle/10665/65516.
  • World Health Organization (WHO). WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creuzfeldt-Jakob disease. Geneva: World Health Organization; 2003.
  • Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain: J Neurol. 2009;132(10):2659–2668. doi:10.1093/brain/awp191
  • Chi NF, Lee YC, Lu YC, Wu HM, Soong BW. Transmissible spongiform encephalopathies with P102L mutation of PRNP manifesting different phenotypes: clinical, neuroimaging, and electrophysiological studies in Chinese kindred in Taiwan. J Neurol. 2010;257(2):191–197. doi:10.1007/s00415-009-5290-419696976
  • Yang CW, Fuh JL, Wang SJ, Lirng JF, Yang CC, Cheng SJ. Probable variant Creutzfeldt-Jakob disease in Asia: a case report from Taiwan and review of two prior cases. Psychiatry Clin Neurosci. 2010;64(6):652–658. doi:10.1111/j.1440-1819.2010.02151.x21155168
  • Creutzfeldt-Jakob Disease International Surveillance Network CJD surveillance data 1993–2018. 2018 Available from: https://www.eurocjd.ed.ac.uk/surveillance data 1.html - scjd-deaths. Accessed 4, 2020.
  • Holman RC, Belay ED, Christensen KY, et al. Human prion diseases in the United States. PLoS One. 2010;5(1):e8521. doi:10.1371/journal.pone.000852120049325
  • Gao C, Shi Q, Tian C, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231. doi:10.1371/journal.pone.002423121904617
  • Ta AT, Huang SE, Chiu MJ, et al. Age-related vulnerabilities along the hippocampal longitudinal axis. Hum Brain Mapp. 2012;33(10):2415–2427. doi:10.1002/hbm.2136421898676
  • Mitrová E, Mayer V, Jovankovicová V, Slivarichová D, Wsólová L. Creutzfeldt-Jakob disease risk and PRNP codon 129 polymorphism: necessity to revalue current data. Eur J Neurol. 2005;12(12):998–1001. doi:10.1111/j.1468-1331.2005.01110.x16324095
  • Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–1591. doi:10.1212/01.WNL.0000160117.56690.B215883321
  • Kobayashi A, Teruya K, Matsuura Y, et al. The influence of PRNP polymorphisms on human prion disease susceptibility: an update. Acta Neuropathol. 2015;130(2):159–170. doi:10.1007/s00401-015-1447-726022925
  • Jeong BH, Nam JH, Lee YJ, et al. Polymorphisms of the prion protein gene (PRNP) in a Korean population. J Hum Genet. 2004;49(6):319–324. doi:10.1007/s10038-004-0150-715148589
  • Yu SL, Jin L, Sy MS, et al. Polymorphisms of the PRNP gene in Chinese populations and the identification of a novel insertion mutation. Eur J Hum Genet. 2004;12(10):867–870. doi:10.1038/sj.ejhg.520124515266305
  • Pocchiari M, Puopolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain: J Neurol. 2004;127(Pt 10):2348–2359. doi:10.1093/brain/awh249
  • Begué C, Martinetto H, Schultz M, et al. Creutzfeldt-Jakob disease surveillance in Argentina, 1997–2008. Neuroepidemiology. 2011;37(3–4):193–202. doi:10.1159/00033190722067221
  • Lundberg PO. Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry. 1998;65(6):836–841. doi:10.1136/jnnp.65.6.8369854958
  • Iwasaki Y, Akagi A, Mimuro M, Kitamoto T, Yoshida M. Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease. J Neurol Sci. 2015;357(1–2):63–68. doi:10.1016/j.jns.2015.06.06526143527
  • Chen YH, Ho CH, Huang CC, et al. Comparison of healthcare utilization and life-sustaining interventions between elderly patients with dementia and those with cancer near the end of life: a nationwide, population-based study in Taiwan. Geriatr Gerontol Int. 2017;17(12):2545–2551. doi:10.1111/ggi.1308428620978
  • Fiorini M, Iselle G, Perra D, et al. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci. 2020;21(3):880. doi:10.3390/ijms21030880
  • Sharma DK, Boggild M, van Heuven AW, White RP. Creutzfeldt-Jakob disease presenting as stroke: a case report and systematic literature review. The Neurologist. 2017;22(2):48–53. doi:10.1097/NRL.000000000000010728248914
  • Zuhorn F, Hubenthal A, Rogalewski A, et al. Creutzfeldt-Jakob disease mimicking autoimmune encephalitis with CASPR2 antibodies. BMC Neurol. 2014;14:227.25434587
  • Miyazawa N. Creutzfeldt-Jakob disease mimicking alzheimer disease and dementia with lewy bodies-findings of FDG PET with 3-dimensional stereotactic surface projection. Clin Nucl Med. 2017;42(5):e247–e248. doi:10.1097/RLU.000000000000160228240664
  • Hsiao PS, Lee YM, Chu FS, et al. Probable sporadic Creutzfeldt-Jakob disease mimicking focal epilepsy. Epilepsy Behav Case Rep. 2019;11:77–80. doi:10.1016/j.ebcr.2019.01.00630788213
  • Ladogana A, Puopolo M, Poleggi A, et al. High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology. 2005;64(9):1592–1597. doi:10.1212/01.WNL.0000160118.26865.1115883322